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ABSTRACT  32 
Anecdotal reports suggest that Sherpa highlanders demonstrate extraordinary 33 
tolerance to hypoxia at high altitude despite exhibiting lower arterial oxygen 34 
content than acclimatised Lowlanders. This study tested the hypothesis that 35 
Sherpas exposed to hypobaric hypoxia on ascent to 5300m, develop 36 
increased microcirculatory blood flow as a means of maintaining tissue 37 
oxygen delivery. Images of the sublingual microcirculation were obtained from 38 
64 Sherpas and 69 Lowlanders using incident dark field imaging. Serial 39 
measurements were obtained from participants undertaking an ascent from 40 
baseline testing (35m or 1300m) to Everest base camp (5300m), and 41 
following subsequent descent in Kathmandu (1300m). Microcirculatory flow 42 
index and heterogeneity index were used to provide indices of 43 
microcirculatory flow, whilst capillary density was assessed using small vessel 44 
density. Sherpas, when compared to Lowlanders, demonstrated significantly 45 
greater microcirculatory blood flow at Everest Base Camp, but not at baseline 46 
testing or on return in Kathmandu. Additionally, Sherpa blood flow exhibited 47 
greater homogeneity at 5300m and 1300m (descent) when compared to 48 
Lowlanders. Sublingual small vessel density was not different between the 49 
two cohorts at baseline testing or at 1300m, however, at 5300m Sherpas 50 
capillary density was up to 30% greater. These data suggest that Sherpas can 51 
maintain a significantly greater microcirculatory flow per unit time, and flow 52 
per unit volume of tissue at high altitude, when compared to Lowlanders. 53 
These findings support the notion that peripheral vascular factors at the 54 
microcirculatory level may be important in the process of adaptation to 55 
hypoxia. 56 
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 57 
NEW & NOTEWORTHY  58 
Sherpa highlanders demonstrate extraordinary tolerance to hypoxia at high 59 
altitude, yet the physiological mechanisms underlying this remain unknown. In 60 
our prospective study, conducted on healthy volunteers ascending to Everest 61 
Base Camp (5300m), we demonstrated that Sherpas have a higher sublingual 62 
microcirculatory blood flow and greater capillary density at high altitude, when 63 
compared to Lowlanders. These findings support the notion that the 64 
peripheral microcirculation plays a key role in the process of long-term 65 
adaptation to hypoxia.   66 
 67 
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 70 
INTRODUCTION 71 
Anecdotal reports suggest that Sherpa highlanders exhibit extraordinary 72 
tolerance to hypoxia at high altitude. Subjective demonstration of their 73 
remarkable exercise and endurance abilities may be readily observed by 74 
persons trekking and climbing in the Himalayan mountain regions. Having 75 
resided at high altitude for the last 500 generations (2), it is likely that these 76 
observations are underpinned by alterations in their genome, adapted through 77 
the process of natural selection driven by lifelong environmental exposure to 78 
hypobaric hypoxia. Whilst evidence of consequent downstream phenotypic 79 
alterations remains limited, intriguingly it has been demonstrated that Sherpas 80 
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exhibit a lower arterial oxygen content (CaO2) when compared to Lowlanders 81 
who ascend to comparable altitudes (1, 4, 38, 44).  It is thus conceivable that 82 
through the comparison of Lowlander and Highlander genotype-phenotype, 83 
one might uncover adaptive mechanisms that facilitate their apparent hypoxia 84 
tolerance.  85 
The delivery of oxygen to metabolising tissues is a process of both convective 86 
flow within the systemic circulation, and diffusion along oxygen partial 87 
pressure gradients within the tissues.  To date, studies have predominantly 88 
focused on the traditionally described aspects of acclimatisation, those 89 
involving the restoration of CaO2 and systemic oxygen delivery (DO2) (4, 6, 90 
15, 38).  Whilst such studies have failed to provide a universally accepted 91 
explanation for hypoxia tolerance, little attention has been paid to the tissue 92 
components of the oxygen cascade.  Within every tissue of the body, the 93 
microcirculation (anatomically described as blood vessels < 100 μm (26)) 94 
regulates localised blood flow to match micro-regional oxygen demand (9).  95 
As the final step in the convective portion of the oxygen cascade, from where 96 
oxygen diffuses into the surrounding tissues, alterations in the 97 
microvasculature may disrupt the balance between oxygen supply and 98 
demand at a cellular level, thereby acting as a ‘bottleneck’ in the oxygen 99 
cascade.  Accordingly, this potential limiting factor may be reduced or 100 
obviated by maintaining adequate microcirculatory flow per unit time and / or 101 
per unit volume of tissue (functional capillary density), and thus the 102 
microcirculation should be considered important to the development of 103 
hypoxia tolerance (25). This study tested the hypothesis that Sherpas 104 
exposed to hypobaric hypoxia on ascent to 5300m, demonstrate increased 105 
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microcirculatory blood flow and vessel density as a means to maintain oxygen 106 
delivery to the peripheral tissues. 107 
 108 
MATERIALS AND METHODS 109 
Participant selection 110 
Approval for this study was obtained both by the University College London 111 
Research Ethics Committee, and the Nepal Health Research Council (NHRC) 112 
as part of the Xtreme Everest 2 (XE2) research expedition (18). Healthy 113 
Sherpa and Lowlander volunteers were recruited and written consent was 114 
obtained from all participants. Sherpas were defined as being direct 115 
descendants of Nepali Sherpas (for at least two generations), drawn from 116 
communities in the Solukhumbu and Rolwaling valleys.  Lowlanders were 117 
recruited in the UK, they were not descendants from a native high altitude 118 
population (e.g. Tibetan, Andean, Ethiopian), and all were born and lived 119 
below 1000m. 120 
 121 
Study setting 122 
XE2 (29) was conducted from December 2012 to May 2013, and this was one 123 
of the individual studies conducted on the research expedition. Sublingual 124 
microcirculatory data were collected at three locations: ‘Baseline testing’ (BL), 125 
‘Everest Base Camp’ (EBC) (5300m), and on descent in ‘Kathmandu’ (KTM) 126 
(1300m). BL testing was conducted in London (LON) for Lowlanders (35m), 127 
and in KTM (1300m) for Sherpas.  Having departed from KTM, all participants 128 
followed an identical ascent and descent profile. This consisted of a flight from 129 
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KTM to an altitude of 2800m, followed by an 11 day trek to EBC. A total of 130 
three nights were then spent at 5300m, before descent to KTM in 5 days.   131 
 132 
Observation of the sublingual microcirculation 133 
The sublingual microcirculation was visualised using the Cytocam incident 134 
dark field (IDF) imaging video-microscope (Braedius Medical, Huizen, The 135 
Netherlands) (3).  Prior to its use in the study, thorough assessment of this 136 
new video-microscope and its automated analysis software was undertaken. 137 
Results demonstrated that firstly the IDF-camera provided improved image 138 
acquisition of human sublingual microcirculation when compared to the 139 
sidestream dark field (SDF) video-microscope (17). The camera uses 140 
polarised green light (wavelength 548nm) to illuminate the observed tissue. 141 
This light corresponds to one of the isobestic points of oxy- and deoxy-142 
haemoglobin, and thus ensures optimal absorption by red blood cells within 143 
the microvasculature regardless of oxygenation status (20). Absorption of 144 
light by haemoglobin, but not by surrounding tissue, creates a distinct contrast 145 
of dark and light colour respectively, and red blood cells moving through the 146 
mucosal microcirculation thus appear as dark globules moving along the axis 147 
of flow.   148 
At each measurement point, participants were required to rest for ten minutes 149 
in the supine position before any images were obtained.  Images were 150 
subsequently obtained following the standard operating guidelines of Trzeciak 151 
et al. (41), whereby the investigator positioned and focused the IDF camera 152 
under participant’s tongue. Ten seconds of video footage was then digitally 153 
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recorded onto the computer where images were stored for later analysis.  This 154 
process was repeated on each participant until five good quality recordings 155 
had been acquired from separate areas of the sublingual region. Studies were 156 
conducted during the day, and subjects were sheltered from any extremes of 157 
temperature. All images were obtained by one of three researchers, all of 158 
whom were experienced in using the IDF video-microscope. 159 
  160 
Analysis and scoring of microcirculatory video images 161 
IDF data analysis was conducted by two researchers using the AVA 3.0 162 
microcirculatory analysis software (MicroVision Medical, Amsterdam, 163 
Netherlands) (10).  To avoid observer bias during analysis of microcirculatory 164 
films, investigators were blinded to both the study location and cohort identity 165 
by assigning random codes to identify films. To assess for inter-observer 166 
variability, the two observers evaluated a selection of IDF videos (30 films). 167 
Each video was only deemed appropriate for analysis if it adhered to the 168 
‘microcirculation image quality scoring system’ (31), whereby stability, 169 
illumination, duration, focus, content, and pressure artefact are assessed. 170 
Videos were subsequently corrected for background variation, image contrast 171 
optimised, and to compensate for movement artefact, all video images 172 
underwent image stabilisation by the analysis software. After initial automated 173 
vessel detection, every film was checked visually, whereupon incorrectly 174 
identified blood vessels were deleted, and undetected vessels were drawn 175 
manually. Additionally, incorrectly disconnected segments of vessels were 176 
‘chained’, and erroneously connected segments were ‘unchained’.  177 
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In keeping with the consensus statement set out in 2007 (8), the mean score 178 
from each of the five measurements recorded at each altitude was used. IDF 179 
variables measured included the microvascular flow index, heterogeneity 180 
index and vessel density.  181 
i) Microvascular Flow Index (MFI). The magnitude of microvascular perfusion 182 
is commonly evaluated by a semi-quantitative scoring system referred to as 183 
the MFI (5, 12). The MFI is based on the determination of the average or 184 
predominant flow type in the field of view at a given time point. It is quantified 185 
using an ordinal scale as follows: 0 = no flow, 1= intermittent flow, 2 = 186 
sluggish flow, 3 = continuous flow. The ‘vessel by vessel’ approach to MFI 187 
calculation was utilised (11, 12) in this study, in which the mean value of the 188 
MFIs in each individual vessel is calculated. This approach has been best 189 
shown to correlate with both the erythrocyte velocity and the proportion of 190 
perfused small vessels (36), and furthermore demonstrates the closest intra-191 
observer reliability for vessel detection and flow classification (35). 192 
ii) Heterogeneity Index (HI). The flow HI provides information relating to the 193 
presence of microcirculatory distributive alterations and shunting (13). It is 194 
calculated as the highest site flow velocity (i.e. the MFI) minus the lowest site 195 
flow velocity, divided by the mean flow velocity of all sublingual sites at that 196 
time point (42).   197 
iii) Vessel Density. Microcirculatory density is assessed as the vessel density. 198 
The total length of the vessel is divided by the total surface of the analysed 199 
vessel (mm/mm2).  200 
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In each instance, both ‘small vessel density’ (<25 μm diameter) and ‘large 201 
vessel density’ (>25 μm diameter) values are reported. Whilst the former 202 
relates to capillaries (and thus contribute principally to organ perfusion and 203 
are arguably the vessel of greatest significance), the latter are reported as 204 
they are used as a quality control measure to ensure that excessive pressure 205 
was not used in obtaining the videos.  206 
 207 
Physiological measurements 208 
Haemoglobin concentration (Hemocue AB, Hemocue, Sweden) and 209 
haematocrit values (Sigma 1-14 microcentrifuge, Sigma, Germany) were 210 
obtained from whole blood samples.  Peripheral oxygen saturation (Nonin 211 
Onyx 9500, Nonin Medical Inc, Minnesota, USA), heart rate, and blood 212 
pressure (Omron M3H, Moron Healthcare, Japan) were recorded after ten 213 
minutes seated at rest. Mean arterial pressure was calculated from the 214 
systolic and diastolic values.  Participant’s tympanic temperature was 215 
measured from the ear canal (Braun 4020, Kronberg, Germany). 216 
 217 
Statistical analysis 218 
All data were assessed for normality. A Shapiro Wilk’s test (P>0.05), and 219 
visual inspection of their histograms, normal Q-Q plots, and box plots showed 220 
that the data were not normally distributed. Non-parametric tests were 221 
therefore used for statistical analysis with values summarised as median and 222 
interquartile ranges.  Related samples Friedman’s Two-Way Analysis of 223 
Variance by Ranks tests (more than two sites) and related samples Wilcoxon 224 
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Signed Rank Test (between two sites) with Bonferroni correction applied were 225 
used to assess the effect of hypoxia on the peripheral microcirculation.  226 
Sherpa and Lowlander cohorts were compared using the unpaired Mann 227 
Whitney U test.  Data were presented as Box-Whisker plots.  The relationship 228 
between microcirculatory flow and other physiological variables were 229 
assessed individually using Spearman’s Rank correlation coefficient (r). Inter-230 
observer variability for analysis of the IDF images was assessed by 231 
calculating the intra-class correlation coefficient.  All statistical calculations 232 
were performed on SPSS version 21 (IBM, USA), and a p-value of <0.05 was 233 
taken to indicate statistical significance.  234 
 235 
RESULTS 236 
Of the 133 participants (64 Sherpas and 69 Lowlanders) who underwent 237 
baseline testing (BL) testing, 131 (63 Sherpas and 68 Lowlanders) completed 238 
testing at Everest base camp (EBC), and 83 (17 Sherpas and 66 Lowlanders) 239 
in Kathmandu (KTM).  The demographics of the participants are shown in 240 
Table 1, and the information relating to the laboratory environments in Tables 241 
2 and 3.  At each altitude, heart rate (HR), systolic blood pressure (SBP), 242 
diastolic blood pressure (DBP), mean arterial pressure (MAP), haemoglobin 243 
concentration (Hb), haematocrit (Hct), peripheral oxygen saturation (SpO2), 244 
and core temperature were similar between the two cohorts (Table 4). 245 
MFI and HI were used to provide indices of microcirculatory flow.  The MFI for 246 
small vessels (<25μm diameter) did not differ between Sherpas and 247 
Lowlanders at BL (2.81 [2.60–2.98] vs. LL 2.96 [2.62-3.00] respectively), or in 248 
KTM (2.97 [2.75-3.00] vs. 2.84 [2.52-3.00]), however, at EBC Sherpas had a 249 
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significantly higher MFI (3.00 [2.88 -3.00] vs. 2.66 [2.45-2.97]); (p < 0.001) 250 
(Figure 1). The MFI for large vessels (>25μm diameter) did not differ between 251 
Sherpas and Lowlanders at any of the three measurement points.  252 
There was no difference in the small vessel HI between Sherpas or 253 
Lowlanders at BL (0.386 [0.336-0.402] vs. 0.359 [0.336-0.667]), however, 254 
Lowlander values were significantly greater than Sherpa values at both EBC 255 
(0.408 [0.374-0.724] vs. 0.341 [0.333-0.390]); (p < 0.001), and on descent to 256 
KTM (0.392 [0.352-0.667] vs. 0.333 [0.333-0.470]); (p = 0.010) (Figure 2). 257 
Small vessel density (<25 μm diameter) was not different between the two 258 
cohorts at BL, or in KTM, but Sherpas had a significantly greater small vessel 259 
density at EBC (13.83 mm/m2 [11.41-14.52] vs. 10.52 mm/m2 [8.90-11.34]); p 260 
= 0.047) (Figure 3). There was no difference between Sherpas’ and 261 
Lowlanders’ large vessel density (>25 μm diameter) at any site. 262 
There was no correlation between either small vessel MFI, HI, or vessel 263 
density, and any of the measured physiological variables (Hb, Hct, HR, SBP, 264 
DBP, MAP, and SpO2).  265 
Inter-observer variability in IDF image analysis was assessed between two 266 
investigators using the intra-class correlation coefficient. A strong correlation 267 
was demonstrated, 0.89 (95%CI 0.83-0.96). 268 
 269 
DISCUSSION 270 
This study demonstrated differences between Sherpa and Lowlander 271 
microcirculatory responses to sustained hypobaric hypoxia at high altitude.  272 
Whilst no difference in microcirculatory blood flow and capillary density was 273 
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seen between cohorts in normoxia (BL), upon exposure to hypoxia Sherpas 274 
demonstrated significantly greater values for both indices. Hypoxia caused 275 
Sherpas to increase both microcirculatory blood flow and capillary density, 276 
whilst Lowlanders decreased flow, but increased density, however, to a lesser 277 
extent than the Sherpas (Figure 4).  On descent to KTM, the relative increase 278 
in vessel densities for both cohorts persisted, however, blood flow returned to 279 
previous baseline values. 280 
 281 
Numerous studies have attempted to determine the genetic and physiological 282 
differences between the indigenous high altitude Sherpa (and Tibetan) 283 
people, and those who live at low altitude (19). Few of these studies however, 284 
have revealed any marked differences that might explain how this high 285 
altitude population not only live, but seemingly thrive, so effectively under 286 
conditions of chronic environmental hypoxia. In 2007, Erzurum et al (14) 287 
explored the possibility that peripheral blood flow was an important 288 
determinant in long-term adaptation to hypoxia. Venous occlusion 289 
plethysmography (VOP) was utilised to measure blood flow in the forearm of 290 
88 Tibetans at 4200m and 50 sea level residents at 206m. Their results 291 
demonstrated Tibetans to have more than double the forearm blood flow than 292 
American controls. Whilst these results supported earlier works relating to 293 
blood flow (39), and skeletal muscle capillary density (22), notably the data 294 
obtained using VOP in Erzurum’s study relates to total blood flow in the 295 
forearm as opposed to that in the microcirculation per se. The first description 296 
of in vivo microcirculatory changes on ascent to high altitude, coincided with 297 
the introduction of sidestream dark field imaging (21). On ascent to 4900m, 298 
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blood flow in the sublingual vessel was seen to reduce significantly in 12 299 
lowland subjects (30), and similar data were recorded in a further 24 lowland 300 
subjects on ascent to 5300m (28).  301 
The Lowlander MFI data presented supports the findings of Martin et al. (28, 302 
30) whereby flow decreased upon ascent to high altitude. In these 303 
manuscripts it was theorised that the slowing microcirculatory blood flow 304 
demonstrated could in fact be an adaptive response, applied to increase the 305 
erythrocyte tissue transit time and improve oxygen diffusion. This is 306 
conceivable since a prolonged course through the capillary network may 307 
enhance offloading of oxygen in the presence of a reduced partial pressure 308 
gradient between the capillary and mitochondria, particularly when cardiac 309 
output is high, as is the case during exercise. Sherpas by contrast, seem to 310 
utilise brisk flow to maintain localised oxygen delivery.  This in turn may 311 
explain the lower Hb concentration that this population demonstrate after 312 
prolonged exposure to hypobaric hypoxia (4). Undoubtedly, increased Hb 313 
concentration augments CaO2, however, elevated Hct increases blood 314 
viscosity, alters its rheology and at levels greater than 50% may decrease 315 
cardiac output and oxygen delivery (43). Furthermore, elevated Hct 316 
demonstrated in South American resident populations, are associated with an 317 
increased prevalence of chronic mountain sickness and related embolic or 318 
thrombotic events (33). In contrast, it seems Sherpas favour a blunted 319 
erythropoetic response thereby allowing for brisk microvascular blood flow.    320 
The speed of microcirculatory blood flow per se may also be less important 321 
than its nature.  Maintaining a homogenous microcirculatory blood flow, 322 
irrespective of the speed at which the contained blood may flow, could be 323 
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crucial to tissue perfusion.  In this study, ascent to EBC was associated with a 324 
fall in the HI in Sherpas, and an increase in Lowlanders, such that a 325 
significant difference is evident between cohorts at high altitude. A lower HI 326 
equates to more homogenous flow, and the importance of this may be 327 
highlighted in the clinical setting where dysregulated, heterogeneous 328 
microvascular flow is a fundamental mechanism through which tissue hypoxia 329 
occurs in sepsis (7). In either case, whether the important determinant of 330 
tissue oxygenation relates to the speed of blood flow, and / or the 331 
homogenous nature of its flow, Sherpas demonstrate superiority in both. 332 
The descent data observed in this study are also novel. The fact that MFI 333 
values were similar between the two cohorts at BL and KTM, suggests that 334 
the physiological basis underpinning Sherpas’ ability to maximise 335 
microcirculatory blood flow at altitude is transient and hypoxia-dependent. We 336 
do however appreciate that only a small number of Sherpas were studied on 337 
their return to Kathmandu, and thus we are cautious in our interpretation of 338 
these data. 339 
 340 
The data presented illustrating the effects of hypoxic exposure on Sherpa 341 
capillary density is the first of its kind. Whilst no difference in small vessel 342 
density was evident between cohorts at BL, these data demonstrate that 343 
Sherpas have a substantial capacity to increase their capillary numbers.  An 344 
increase in sublingual vessel density on ascent to altitude has been previously 345 
reported by Martin et al (28). That said, in his study conducted on 21 346 
Lowlanders ascending to 5300m, it was not the density of small vessels 347 
(<25μm) which altered at high altitude, but rather that of the larger vessels 348 
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(>25 μm). Whilst the actual values reported by Martin et al for small vessel 349 
density were similar to those seen above, our data contrast with prior data 350 
where we found Lowlanders to increase their small vessel density on ascent 351 
to 5300m (Figure 3) (p=0.020), whilst their large vessel density did not 352 
change.  Whilst both studies used a very similar ascent profile, the 353 
discrepancy between our findings may be due to the increased statistical 354 
power of this study, and / or the fact that we used an IDF video-microscope as 355 
opposed to the SDF video-microscope (17). 356 
 357 
Whilst both cohorts demonstrated increased capillary density on ascent to 358 
high altitude, Sherpas did so to a much greater degree.  At EBC, their 359 
capillary network was approximately 30% denser than Lowlanders.  Vessel 360 
recruitment due to elevated Hb and Hct might have accounted for the rise in 361 
capillary density in both groups (16, 34, 37, 45). These values however, were 362 
similar between the two cohorts upon arrival at EBC, so it seems unlikely that 363 
this explains the observed difference between them, unless Sherpas have a 364 
much larger un-recruited (and thus unseen) reservoir in normoxia. This is 365 
certainly plausible, and as with flow, it is likely that the difference is ultimately 366 
underpinned by genetic differences. 367 
 368 
This is the first study of Sherpa microcirculation on ascent to, and descent 369 
from high altitude. A large number of participants were studied, and over 98% 370 
successfully ascended to EBC following an identical ascent profile. This 371 
matched ascent profile along with serial measurements controls for variability 372 
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of exposure to hypoxia, and thereby enables valid inter-individual comparison 373 
of hypoxia responses whilst amplifying the signal to noise ratio (24). The 374 
newly released Cytocam video-microscope was used to obtain images of the 375 
sublingual microcirculation, and our assessment of it prior to the expedition 376 
demonstrated its superior capabilities regarding image acquisition compared 377 
its predecessor SDF imaging (17). Unfortunately, no validation of the camera 378 
in a hypobaric hypoxic environment was performed prior to the expedition, 379 
and this is a limitation of the study. Further limitations include potential 380 
recruitment bias, confounding factors within laboratories, the different altitude 381 
for baseline testing in Sherpas (1300m) and Lowlanders (35m), and the small 382 
number of Sherpas tested on descent.  Whilst recruitment was through open 383 
advertisement and word of mouth, the participants were self-selecting by 384 
virtue of this research expedition involving opportunistic observation of 385 
individuals with a desire to visit the study environment, and thus may not be 386 
truly representative of a ’normal’ Sherpa or Lowlander population. The 387 
demographic data (Table 1) demonstrates that approximately equal numbers 388 
of participants were compared, with a similar gender ratio in each group, 389 
however, the age of participants was markedly lower in the Sherpa cohort, 390 
whilst the percentage of smokers was higher.  Smoking is known to affect the 391 
vasculature and could thus be a confounding factor in the results (32).  392 
Despite our best efforts to minimise temperature differences between 393 
laboratories, disparities were still seen. This could affect microvascular flow 394 
due to cold-induced vasoconstriction (23, 40).  There were, however, no 395 
significant differences between the environmental temperatures both cohorts 396 
were exposed to within each individual laboratory (Table 3).  Additionally, as 397 
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the sublingual circulation is within the oral cavity, and as such it is regarded as 398 
being at a similar temperature to one’s core, the data demonstrated no 399 
differences in the two cohorts’ tympanic temperatures (Table 4).  Other 400 
potential confounding factors specific to the high altitude environment include 401 
hydration status which in turn may affect Hct values, and thus alter blood 402 
rheology. The effect of this potential confounding factor was minimised by 403 
conducting studies at all altitudes after a period of overnight rest and ensuring 404 
subjects had free access to oral fluids and were actively encouraged to drink 405 
enough fluid to produce normal volumes of clear urine.  Finally, ascent to 406 
altitude may cause tissue oedema (27), which if occurring in the sublingual 407 
mucosa could theoretically affect image quality and lead to false 408 
measurements of flow and density. Baseline testing was conducted in London 409 
for Lowlanders (35m), and in Kathmandu (1300m) for Sherpas due to 410 
logistical restraints. The reasoning behind this was twofold. Firstly, it would 411 
not have been pragmatic or financially viable to fly all Sherpas to London for 412 
their baseline testing. Secondly, data from Caudwell Xtreme Everest 2007 413 
(24) had failed to identify any significant differences in participants’ physiology 414 
between the sea level and Kathmandu (1300m) laboratories; thus we believed 415 
it to be scientifically appropriate to use these two distinct locations for baseline 416 
testing.  Lastly the notable deficit in Sherpas tested on descent in Kathmandu 417 
should be highlighted. Forty-six Sherpas were not tested in Kathmandu 418 
having previously been tested at EBC. This was the result of logistical 419 
constraints. 420 
 421 
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In conclusion, this study suggests that adaptation to hypoxia in the Sherpa 422 
sublingual microcirculation involves increasing both microcirculatory blood 423 
flow and capillary density.  In turn, teleological reasoning would suggest that 424 
this results in a greater oxygen delivery both per unit time, and per unit 425 
volume of tissue.  It remains unclear whether these microvascular alterations 426 
are restricted to the sublingual microcirculation, or what underlying 427 
biochemical and physiological factors facilitate the changes in blood flow and 428 
vessel density, and further work is required to explore these questions.  429 
  430 
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Figure 1. Small vessel (<25μm) microvascular flow index (MFI) in Sherpas and Lowlanders 
on ascent to and descent from high altitude 
 
*  = Significant difference demonstrated between cohorts at that site. 
^ = Significant difference demonstrated for that cohort between relevant site and BL. 
Fig 1. Ascent to high altitude caused Sherpa microvascular flow index (MFI) to increase from 
Baseline, whilst Lowlanders’ decreased (^).  A significant difference is demonstrated between 
Sherpa and Lowlanders small vessel MFI at Everest Base Camp (*).  
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Figure 2. Small vessel (<25μm) heterogeneity index in Sherpas and Lowlanders on ascent 
and descent from high altitude 
 
*  = Significant difference demonstrated between cohorts at that site. 
^ = Significant difference demonstrated for that cohort between relevant site and BL. 
Fig 2. Sherpas heterogeneity index (HI) was seen to decrease at Everest Base Camp (EBC) 
and Kathmandu (KTM) compared to Baseline (BL), whilst Lowlanders increased at EBC (^). 
A significant difference was seen between cohorts HI at EBC and KTM (*). 
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Figure 3. Small vessel (<25μm) density in Sherpas and Lowlanders on ascent and descent 
from high altitude 
 
 
*  = Significant difference demonstrated between cohorts at that site. 
^ = Significant difference demonstrated for that cohort between relevant site and BL. 
Fig 3. Sherpas small vessel density (VD) can be seen to increase at Everest Base Camp 
(EBC), and remains higher than Baseline values on return to Kathmandu (KTM) (^). 
Lowlanders VD increases at EBC (^), but then returns to Baseline values on return to KTM. 
At EBC, Sherpas demonstrate a significantly larger VD compared to Lowlanders (*). 
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Figure 4: Depiction of the changes in sublingual small vessel density and microvascular flow 
occurring on ascent to, and descent from, high altitude. 
 
Fig 4. On ascent to high altitude, Sherpas are seen to increase dramatically both their small vessel 
density, and microvascular flow in a uniform and homogenous manner. On re-exposure to 
normoxia, flow returns to previous baseline values, but whilst vessel density decreases, it still 
remains greater than initial baseline values. Lowlanders also increase their small vessel density 
on ascent to high altitude but to a far lesser extent than Sherpas. Their microvascular flow 
decreases, however not in a uniform manner such that it has become heterogenous in nature.   On 
re-exposure to normoxia, both vessel density and flow return to baseline values.	
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Table 1: Demographic summary of participants  
 Sherpas Lowlanders 
Number 64 69 
Gender (% male) 47% 39% 
Age (years) 27.9 (±6.9) 41.3 (±13.9) 
Height (cm) 160 (±6) 171 (±10) 
Weight (kg)  71.1 (±13.5) 61.3 (±8.9) 
Smokers 14 (±21%) 6 (±8.6%) 
 
Values for age, height, weight and smokers are presented as mean value (± standard 
deviation). 
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Table 2: Laboratory environmental conditions  
Laboratory Altitude 
(m) 
Barometric 
pressure  
(kPa) 
Temperature 
(oC) 
Humidity 
(%) 
PO2 
(kPa) 
London 35 100.6 (±0.2) 16.9 (±1.8) 35.4 (±6.5) 21.0 
Everest Base 
Camp 
5300 53.0 (±0.2) 12.9 (±8.2) 37.8 (±17.5) 11.0 
Kathmandu 1300 86.8 (±0.4) 23.8 (±3.4) 47.4 (±15.7) 18.1 
 
Barometric pressures, temperature and humidity are mean (± standard deviation) values 
recorded during laboratory testing in the field. PO2 = calculated from barometric pressures 
assuming FiO2 0.209. 	
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Table 3: Laboratory temperature and partial pressure of oxygen according to study cohort  
 
 
Baseline^ Everest Base 
Camp 
Kathmandu 
(Descent) 
Sh LL Sh LL Sh LL  
Laboratory 
temperature, °C 
16.9 
(±1.8) 
22.6 
(±3.2) 
12.6  
(±8.4) 
12.9  
(±7.9) 
23.8   
(±3.3) 
24.1   
(±3.1) 
PIO2, kPa 16.8 19.8 9.8 9.8 16.8 16.8 
^ Baseline testing for Lowlanders (LL) was in London, and baseline testing for Sherpas (Sh) 
was in Kathmandu. Both cohorts were tested in Kathmandu on descent. Values are mean (± 
standard deviation). 
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Table 4: Physiological variables for participants during the study  
Laboratory HR SBP 
(mmHg) 
DBP  
(mmHg) 
MAP  
(mmHg) 
SpO2  
(%) 
Hb  
(g/l) 
Hct  
(%) 
Core 
temperature 
(oC) 
Sh LL Sh LL Sh LL Sh LL Sh LL Sh LL Sh LL Sh LL 
Baseline 
69 
(10) 
64  
(9) 
121 
(10) 
127 
(19) 
81 
(10) 
79 
(10) 
94 
(9) 
95 
(13) 
97  
(1) 
98 
(1.2) 
137 
(16) 
141 
(14) 
43 
(4.5) 
43 
(3.9) 
36.3 
(0.5) 
36.3 
(0.4) 
Everest Base 
Camp 
87 
(10) 
77 
(14) 
125 
(13) 
132 
(16) 
89 
(11) 
86 
(8) 
101 
(11) 
101 
(10) 
78  
(5) 
79 
(5.3) 
151 
(17) 
153 
(20) 
49 
(4.5) 
49 
(5.7) 
36.2 
(0.6) 
36.1 
(0.7) 
Kathmandu  
75 
(13) 
68 
(12) 
112 
(8) 
122 
(15) 
75 
(9) 
80 
(8) 
87 
(8) 
95 
(10) 
95 
(7) 
97 
(1.4) 
140 
(13) 
145 
(20) 
43 
(3.4) 
46 
(5.8) 
36.1 
(0.4) 
36.2 
(0.5) 
 
Fig 4. The mean (± standard deviation) values for Sherpa (Sh) and Lowlander (LL) heart rate (HR), Systolic blood pressure (SBP), diastolic blood 
pressure (DBP), mean arterial pressure (MAP), peripheral oxygen saturations (SpO2), haemoglobin concentration (Hb), haematocrit (Hct), and 
core temperature at each laboratory. 
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